![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Petzold, Tobias; Thienel, Manuela; Dannenberg, Lisa; Mourikis, Philipp; Helten, Carolin; Ayhan, Aysel; M'Pembele, Rene; Achilles, Alina; Trojovky, Kajetan; Konsek, Daniel; Zhang, Zhe; Regenauer, Ron; Pircher, Joachim; Ehrlich, Andreas; Luesebrink, Enzo; Nicolai, Leo; Stocker, Thomas J.; Brandl, Richard; Roeschenthaler, Franz; Strecker, Jan; Saleh, Inas; Spannagl, Michael; Mayr, Christoph H.; Schiller, Herbert B.; Jung, Christian; Gerdes, Norbert; Hoffmann, Till; Levkau, Bodo; Hohlfeld, Thomas; Zeus, Tobias; Schulz, Christian; Kelm, Malte und Polzin, Amin
(2020):
Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.
In: Circulation Research, Bd. 126, Nr. 4: S. 486-500
Polzin, Amin; Dannenberg, Lisa; Wolff, Georg; Helten, Carolin; Achilles, Alina; Hohlfeld, Thomas; Zeus, Tobias; Kelm, Malte; Massberg, Steffen und Petzold, Tobias
(2019):
Non-vitamin K oral anticoagulants (NOAC) and the risk of myocardial infarction: Differences between factor IIa and factor Xa inhibition?
In: Pharmacology & Therapeutics, Bd. 195: S. 1-4
Dannenberg, Lisa; Petzold, Tobias; Achilles, Alina; Naguib, David; Zako, Saif; Helten, Carolin; M'Pembele, Rene; Mourikis, Philipp; Podsvyadek, Yanina; Grandoch, Maria; Levkau, Bodo; Zeus, Tobias; Kelm, Malte; Hohlfeld, Thomas und Polzin, Amin
(2019):
Dose reduction, oral application, and order of intake to preserve aspirin antiplatelet effects in dipyrone co-medicated chronic artery disease patients.
In: European Journal of Clinical Pharmacology, Bd. 75, Nr. 1: S. 13-20